Systems Biology Based Drug Repositioning for Development of Cancer Therapy
Loading...

Date
2021
Authors
Turanli, Beste
Altay, Ozlem
Boren, Jan
Turkez, Hasan
Nielsen, Jens
Uhlen, Mathias
Mardinoglu, Adil
Journal Title
Journal ISSN
Volume Title
Publisher
Academic Press Ltd- Elsevier Science Ltd
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Drug repositioning is a powerful method that can assists the conventional drug discovery process by using existing drugs for treatment of a disease rather than its original indication. The first examples of repurposed drugs were discovered serendipitously, however data accumulated by high-throughput screenings and advancements in computational biology methods have paved the way for rational drug repositioning methods. As chemotherapeutic agents have notorious side effects that significantly reduce quality of life, drug repositioning promises repurposed noncancer drugs with little or tolerable adverse effects for cancer patients. Here, we review current drug-related data types and databases including some examples of web-based drug repositioning tools. Next, we describe systems biology approaches to be used in drug repositioning for effective cancer therapy. Finally, we highlight examples of mostly repurposed drugs for cancer treatment and provide an overview of future expectations in the field for development of effective treatment strategies.
Description
Turanli, Beste/0000-0003-1330-9712; Uhlen, Mathias/0000-0002-4858-8056
Keywords
Systems Biology, Cancer, Drug Repositioning, Signature-Based Approaches, Network-Based Approaches
Fields of Science
Citation
WoS Q
Q1
Scopus Q
Q1
Source
Seminars in Cancer Biology
Volume
68
Issue
Start Page
47
End Page
58
